Implementation of COVID-19 Testing Strategies in Community Health Centers

NCT04802187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-11-08

Study results available
· View outcomes & findings →

Summary

This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.

Conditions

  • Covid19

Interventions

OTHER

RADx CHCs testing intervention strategy

The study team will support partner CHCs to implement workflows with some combination of dedicated testing staff, off-site testing, outreach/communications to priority populations, and linkage with local contact tracing systems. Implementation support will take the form of practice facilitation, rapid cycle testing (by supporting CHCs to review their internal data to assess the impact of workflow changes), and expert consultation from the research team on testing technology and testing location design.

OTHER

Usual care control

CHCs implement testing strategies in accordance with their usual supports.

Sponsors & Collaborators

  • Dana-Farber Cancer Institute

    collaborator OTHER
  • Harvard School of Public Health (HSPH)

    collaborator OTHER
  • Massachusetts League of Community Health Centers

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Elsie Taveras, MD, MPH · Massachusetts General Hospital

  • Karen Emmons, PhD · Harvard School of Public Health (HSPH)

  • Susan Dargon-Hart, LICSW · Massachusetts League of Community Health Centers

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-07-15
Completion
2022-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802187 on ClinicalTrials.gov